Home \ Expert Opinion \ Rehabilitation after Covid-19

Rehabilitation after Covid-19

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Neurological symptoms after coronavirus infection
04:49
Multidisciplinary management of patients with COVID-19
06:00
Safety of breathing exercises with pulmonary failure
09:25
Features of the selection of therapy in patients with post -shoe syndrome
12:00
The main mechanisms of the development of complications
12:35
Mexidol® - multimodal neurocytoprotector
15:53
The use of Mexidol® in the treatment of post -shoe disorders
18:00
Clinical examination of the use of Mexidol® in patients with COVID-19

Ekusheva Evgenia Viktorovna - MD, professor, head. Department of Nervous Diseases and Neurorebition of the Academy of Postgraduate Education of the Federal State Budgetary Educational Institution of the FGBC FMBA of Russia

Kovalchuk Vitaly Vladimirovich -MD, professor, chairman of the Society of Rehabilitologists of St. Petersburg, head. department of neurological rehabilitation of St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko "

Announcement:

Oxidative stress and energy deficiency are the main mechanisms of pathogenesis of neurological disorders after coronaviral infection. Therefore, for patients who have undergone Covid-19, antioxidants, antihypoxants and energy corruption are needed. Mexidol ® is a pathogenetically justified remedy that helps treat neurological disorders. Mexidol® after coronavirus , as a result of the restoration of the energy synthetic function of mitochondria and neutralization of oxidative stress in nervous tissue, reduces the severity of asthenia, improves sleep and cognitive functions. Studies of the drug Mexidol® have shown that it also reduces the symptoms of chronic brain ischemia, improving the quality of life of patients who have undergone coronavirus infection.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Neurological symptoms after coronavirus infection
04:49
Multidisciplinary management of patients with COVID-19
06:00
Safety of breathing exercises with pulmonary failure
09:25
Features of the selection of therapy in patients with post -shoe syndrome
12:00
The main mechanisms of the development of complications
12:35
Mexidol® - multimodal neurocytoprotector
15:53
The use of Mexidol® in the treatment of post -shoe disorders
18:00
Clinical examination of the use of Mexidol® in patients with COVID-19

Block of articles on this topic

The effectiveness of Mexidol Correction in the correction of the post -shoe syndrome in patients with chronic cerebrovascular diseases

Authors:

E.B. Kuznetsova, E.A. Salina, N.S. Kuznetsov

FSBEI in "Saratov State Medical University named after V.I. Razumovsky "Ministry of Health of Russia, Saratov, Russia

The role of antioxidant therapy in patients with the new coronavirus infection of the Covid-19 of the Motenza and Severe

Authors:
E.K. Shavarova ^1.2 , E.R. Kazamedov ¹ , M.V. Alekseeva ¹ , L.G. Yezhova ² , railway Cobalava ¹

¹ Russian University of Friendship of Peoples (RUDN), Moscow, Russian Federation;
² City Clinical Hospital named after V.V. Vinogradov Department of Health of the city of Moscow, Moscow, Russian Federation

The role of free-radical oxidation, hypoxia and their correction in the pathogenesis of Covid-19

Authors:
A.V. Schulkin, A.A. Filimonova

FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia

Clinical and psychological profile and quality of life of patients with post-shoe syndrome

Authors:
L.V. Chichanovskaya, T.A. Slyusar, Yu.V. Abramenko, T.M. Nekrasova, I.N. Slyusar

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Neurological manifestations of post -shoe syndrome

Authors:

P.R. Kamchatnov ¹ , R.A. Cheremin ² , L.A. Scepterova ² , A.V. Chugunov ¹

¹ FBGOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² GBUZ "Center for Pathology of Speech and Neurorebition of the Moscow Department of Health", Moscow, Russia.

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com